Journal of Thrombosis and Haemostasis, 1538-7933

Journal

More filtering options
  1. 2020
  2. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study

    Alberto Tosetto, Zahra Badiee, Mohammad Reza Baghaipour, Luciano Baronciani, Javier Battle, Erik Berntorp, Imre Bodó, Ulrich Budde, Giancarlo Castaman, Jeroen C.J. Eikenboom, Peyman Eshghi, Cosimo Ettorre, Anne Goodeve, Jenny Goudemand, Charles Richard Morris Hay, Hamid Hoorfar, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W.G. Leebeek & 15 others, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Maria Gabriella Mazzucconi, Massimo Morfini, Johannes Oldenburg, Ian Peake, Rafael Parra Lòpez, Flora Peyvandi, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Marc Trossaert, Omidreza Zekavat, Eva M.K. Zetterberg & Augusto B. Federici, 2020 Sep 1, In : Journal of Thrombosis and Haemostasis. 18, 9, p. 2145-2154 10 p.

    Research output: Contribution to journalArticle

  3. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysis

    Toshihiko Takada, Sander van Doorn, Sameer Parpia, Kerstin de Wit, David R. Anderson, Scott M. Stevens, Scott C. Woller, Arina J. ten Cate-Hoek, Johan L. Elf, Roderik A. Kraaijenhagen, Roger E.G. Schutgens, Phil S. Wells, Clive Kearon, Karel G.M. Moons & Geert Jan Geersing, 2020 May 20, In : Journal of Thrombosis and Haemostasis.

    Research output: Contribution to journalArticle

  4. Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays

    Andreas Hillarp, Karin Strandberg, Kerstin M. Gustafsson & Tomas L. Lindahl, 2020 Apr 15, In : Journal of Thrombosis and Haemostasis.

    Research output: Contribution to journalArticle

  5. Detection of F8 int22h inversions using digital droplet PCR and mile-post assays

    Eric Manderstedt, Christina Lind-Halldén, Rolf Ljung, Jan Astermark & Christer Halldén, 2020 Feb 7, In : Journal of Thrombosis and Haemostasis.

    Research output: Contribution to journalArticle

  6. 2019
  7. 2018
  8. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity

    M. Olsson, T. M. Stanne, A. Pedersen, E. Lorentzen, E. Kara, A. Martinez-Palacian, N. P. Rønnow Sand, A. F. Jacobsen, P. M. Sandset, J. J. Sidelmann, G. Engström, O. Melander, S. M. Kanse & C. Jern, 2018, In : Journal of Thrombosis and Haemostasis. 16, 10, p. 2024-2034

    Research output: Contribution to journalArticle

  9. 2017
  10. Effect of late prophylaxis in hemophilia on joint status: A randomized trial

    M. J. Manco-Johnson, B. Lundin, S. Funk, C Peterfy, D. Raunig, M. Werk, C L Kempton, M. T Reding, S. Goranov, L. Gercheva, L Rusen, M. V. Uscatescu, Marina Pierdominici, S. Engelen, J. Pocoski, D. Walker & W Hong, 2017 Nov, In : Journal of Thrombosis and Haemostasis. 15, 11, p. 2115-2124

    Research output: Contribution to journalArticle

  11. Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: Results of the INSIGHT case-control study

    Alice S. van Velzen, C. L. Eckhardt, M. Peters, F. W. G. Leebeek, C. Escuriola-Ettingshausen, C Hermans, Russell D. Keenan, J. Astermark, Christoph Male, K Peerlinck, Saskia le Cessie, J. G. Van der Bom & K. Fijnvandraat, 2017 Jul 3, In : Journal of Thrombosis and Haemostasis. 15, 7, p. 1422-1429

    Research output: Contribution to journalArticle

  12. 2016
  13. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    A. E. Bowyer, A. Hillarp, M. Ezban, P. Persson & S. Kitchen, 2016, In : Journal of Thrombosis and Haemostasis. 14, 7, p. 1428-1435

    Research output: Contribution to journalArticle

  14. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Ari Brekkan, Erik Berntorp, Kirsten Jensen, Elisabet I Nielsen & Siv Jönsson, 2016, In : Journal of Thrombosis and Haemostasis. 14, 4, p. 724-732

    Research output: Contribution to journalArticle

  15. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.

    R Tuckuviene, S Ranta, B K Albertsen, N G Andersson, M D Bendtsen, T Frisk, M W Gunnes, J Helgestad, M M Heyman, O G Jonsson, A Mäkipernaa, K Pruunsild, Ulf Tedgård, S S Trakymiene & E Ruud, 2016, In : Journal of Thrombosis and Haemostasis. 14, 3, p. 485-494

    Research output: Contribution to journalArticle

  16. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

    Huda Kozarcanin, Christian Lood, Lea Munthe-Fog, Kerstin Sandholm, Osama A Hamad, Anders Bengtsson, Mikkel-Ole Skjoedt, Markus Huber-Lang, Peter Garred, Kristina N Ekdahl & Bo Nilsson, 2016, In : Journal of Thrombosis and Haemostasis. 14, 3, p. 531-545

    Research output: Contribution to journalArticle

  17. 2015
  18. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.

    Kenny M Hansson, David Gustafsson, Tor Skärby, Lars Frison & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 7, p. 1293-1300

    Research output: Contribution to journalArticle

  19. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    T Abshire, J Cox-Gill, C L Kempton, F W G Leebeek, M Carcao, P Kouides, S Donfield & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 9, p. 1585-1589

    Research output: Contribution to journalArticle

  20. 2014
  21. Definitions in hemophilia: communication from the SSC of the ISTH

    V. S. Blanchette, N. S. Key, Rolf Ljung, M. J. Manco-Johnson, H. M. Van Den Berg & A. Srivastava, 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1935-1939

    Research output: Contribution to journalArticle

  22. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

    Andreas Hillarp, Kerstin M Gustafsson, Lars Faxälv, Karin Strandberg, Fariba Baghaei, Inger Fagerberg Blixter, Maria Berndtsson & Tomas L Lindahl, 2014, In : Journal of Thrombosis and Haemostasis. 12, 9, p. 1545-1553

    Research output: Contribution to journalArticle

  23. Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

    M. Hultcrantz, R. M. Pfeiffer, M. Bjorkholm, L. R. Goldin, Ingemar Turesson, S. Schulman, O. Landgren & S. Y. Kristinsson, 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1816-1821

    Research output: Contribution to journalArticle

  24. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    C. L. Eckhardt, Jan Astermark, S. Q. Nagelkerke, J. Geissler, M. W. T. Tanck, M. Peters, K. Fijnvandraat & T. W. Kuijpers, 2014, In : Journal of Thrombosis and Haemostasis. 12, 8, p. 1294-1301

    Research output: Contribution to journalArticle

  25. 2013
  26. 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.

    Rolf Ljung, F A Karim, K Saxena, Toru Suzuki, P Arkhammar, A Rosholm & P Giangrande, 2013, In : Journal of Thrombosis and Haemostasis. 11, 7, p. 1260-1268

    Research output: Contribution to journalArticle

  27. Origin of Swedish hemophilia B mutations

    C. Hallden, Annika Mårtensson, D. Nilsson, Torbjörn Säll, C. Lind-Hallden, A. C. Liden & Rolf Ljung, 2013, In : Journal of Thrombosis and Haemostasis. 11, 11, p. 2001-2008

    Research output: Contribution to journalArticle

  28. 2012
  29. Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.

    P Knoebl, M Paese, F Baudo, P Collins, A Huth-Kühne, L Nemes, F Pellegrini, Lilian Tengborn & H Lévesque, 2012, In : Journal of Thrombosis and Haemostasis. 10, 4, p. 622-631

    Research output: Contribution to journalArticle

  30. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    C A Clark, R Vatsyayan, Ulla Hedner, C T Esmon, U R Pendurthi & L V M Rao, 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2383-2391

    Research output: Contribution to journalArticle

  31. Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?

    C. Hermans, Jan Astermark & P. De Moerloos, 2012, In : Journal of Thrombosis and Haemostasis. 10, 10, p. 2194-2196

    Research output: Contribution to journalLetter

  32. Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

    S Y Kristinsson, L Goldin, Ingemar Turesson, M Hultcrantz, M Björkholm & O Landgren, 2012, In : Journal of Thrombosis and Haemostasis. 10, 5, p. 962-964

    Research output: Contribution to journalLetter

  33. Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

    R Gopalakrishnan, U R Pendurthi, Ulla Hedner, H Agersø, C T Esmon & L V M Rao, 2012, In : Journal of Thrombosis and Haemostasis. 10, 5, p. 971-973

    Research output: Contribution to journalLetter

  34. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).

    I Pabinger, C Y Vossen, J Lang, J Conard, M C García-Dabrio, W Miesbach, C Legnani, Peter Svensson, A Kaider & F R Rosendaal, 2012, In : Journal of Thrombosis and Haemostasis. 10, 2, p. 217-222

    Research output: Contribution to journalArticle

  35. Origin of Swedish hemophilia A mutations

    C. Halldén, D. Nilsson, Torbjörn Säll, C. Lind-Hallden, A. C. Liden & Rolf Ljung, 2012, In : Journal of Thrombosis and Haemostasis. 10, 12, p. 2503-2511

    Research output: Contribution to journalArticle

  36. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    P W Collins, J Møss, Karin Knobe, A Groth, T Colberg & E Watson, 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2305-2312

    Research output: Contribution to journalArticle

  37. 2011
  38. Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden

    R. Ljung & ANNIKA MÅRTENSSON, 2011 Jul 1, In : Journal of Thrombosis and Haemostasis. 9, p. 462 1 p., P-TU-492.

    Research output: Contribution to journalPublished meeting abstract

  39. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).

    A Gringeri, Björn Lundin, S V Mackensen, L Mantovani & P M Mannucci, 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 700-710

    Research output: Contribution to journalArticle

  40. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

    Andreas Hillarp, F Baghaei, I F Blixter, K M Gustafsson, L Stigendal, M Sten-Linder, Karin Strandberg & T L Lindahl, 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 133-139

    Research output: Contribution to journalArticle

  41. Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.

    G M A van Os, J C M Meijers, C Ağar, M Valls Serón, J A Marquart, Per Åkesson, R T Urbanus, R H W M Derksen, Heiko Herwald, Matthias Mörgelin & P G de Groot, 2011, In : Journal of Thrombosis and Haemostasis. 9, 12, p. 2447-2456

    Research output: Contribution to journalArticle

  42. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    H Agersø, D F Brophy, H Pelzer, E J Martin, M Carr, Ulla Hedner & M Ezban, 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 333-338

    Research output: Contribution to journalArticle

  43. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).

    A Tiede, Ute Friedrich, C Stenmo, G Allen, P Giangrande, J Goudemand, C Hay, Eva M Holmström, R Klamroth, Stefan Lethagen, S McKenzie, W Miesbach, C Negrier, V J Yuste & Erik Berntorp, 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 1191-1199

    Research output: Contribution to journalArticle

  44. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Carl Högberg, Olof Gidlöf, Chanyuan Tan, Siv Svensson, Jenny Öhman, David Erlinge & Björn Olde, 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 361-372

    Research output: Contribution to journalArticle

  45. Wide temperature range testing with sonoclot plateletfunction and ROTEM EXTEM/FIBTEM/APTEM test

    Ulf Schött, Jens Brokopp, Jan Mårtensson, Attila Frigyesi & Hans Friberg, 2011, In : Journal of Thrombosis and Haemostasis. 9, s2, p. 91 1 p., P-MO-104.

    Research output: Contribution to journalPublished meeting abstract

  46. 2010
  47. APC-PCI complex as new tool for the evaluation of anticoagulant response to endogenous thrombin formation and its sequel in fibrinolysis

    C. Kluft, Johan Stenflo, P. Meijer & J. Burggraaf, 2010, In : Journal of Thrombosis and Haemostasis. 8, p. 58-58

    Research output: Contribution to journalPublished meeting abstract

  48. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Valls M. Seron, P. F. Marx, J. A. Marquart, Heiko Herwald, P. G. de Groot & J. C. M. Meijers, 2010, In : Journal of Thrombosis and Haemostasis. 8, p. 20-21

    Research output: Contribution to journalPublished meeting abstract

  49. Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

    R. Gopalakrishnan, Ulla Hedner, S. Ghosh, R. C. Nayak, T. C. Allen, U. R. Pendurthi & L. V. M. Rao, 2010, In : Journal of Thrombosis and Haemostasis. 8, 2, p. 301-310

    Research output: Contribution to journalArticle

  50. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.

    Carl Ekman, Jonas Stenhoff & Björn Dahlbäck, 2010, In : Journal of Thrombosis and Haemostasis. 8, 4, p. 838-844

    Research output: Contribution to journalArticle

  51. Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.

    Andreas Hillarp, M Stadler, C Haderer, J Weinberger, C M Kessler & J Römisch, 2010, In : Journal of Thrombosis and Haemostasis. 8, p. 2216-2223

    Research output: Contribution to journalArticle

  52. rFVIIa transported from the blood stream into tissues is functionally active

    R. Gopalakrishnan, Ulla Hedner, C. Clark, U. R. Pendurthi & L. V. M. Rao, 2010, In : Journal of Thrombosis and Haemostasis. 8, 10, p. 2318-2321

    Research output: Contribution to journalLetter

  53. The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.

    Cecilia Oslakovic, M Jauhiainen, C Ehnholm & Björn Dahlbäck, 2010, In : Journal of Thrombosis and Haemostasis. 8, p. 766-772

    Research output: Contribution to journalArticle

Previous 1 2 3 Next